Trial Profile

Phase II trial of autologous cell replacement therapy in patients with type-1 diabetes mellitus

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 10 Jun 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cell replacements (Primary)
Indications Type 1 diabetes mellitus
Focus Therapeutic Use

Most Recent Events

09 Jun 2015 According to an Orgenesis media release, the company plans to initiate this trial in next 12 - 18 months.
10 Apr 2015 Orgenesis has signed a memorandum of understanding with MaSTherCell in Belgium (9165439) and CureCell in South Korea (9177154), so this trial could be in either country.
09 Apr 2015 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com